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The influence of the phospholipid analoguc hexadecylphosphocholine on phosphatidylcholine biosynthesis was investigated in Madin-Darby canine 
kidney (MDCK) cells. It inhibits the incorporation rate of [merl~ylJH]cholinc into phosphatidylcholinc at a concentration of 50 /IM by about 50%. 
The radiolabelled precursor accumulates in the phosphocholine pool indicating that hexadccylphosphocholine inhibits the formation of phosphati- 
dylcholine via the GDP-choline pathway at the level of the rate-limiting enzyme, CTPzphosphocholine cytidylyl transfcrase (EC 2.7.7.15). This was 
verified by the determination of the activity of the enzyme in vitro. In consequence of its inhibitory effect it could be shown that the treatment 
of MDGK cells for 24 h with SO PM hexadecylphosphocholine induces alterations of the phospholipid composhion. Whereas in treated cells the 
relative phosphatidylcholinc content was decreased from the control level of 36.0&0.9% to 29.9&0.2%; in contrast, the relative content of phosphati- 
dylethanolaminc was increased from 19.3_+0.9% to 24.3&0.9%. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
In mammalian tissues the most abundant phospholi- 
pid is phosphatidylcholine. Its biosynthesis was the sub- 
ject of several investigations (for review see [I I). Studies 
on the influence of alkyllysophosphoglycerides on 
phospholipid metabolism demonstrated that these 
analogues disturb especially the metabolism of phos- 
phatidylcholine [2]. In contrast to the previously in- 
vestigated analogues, hexadecylphosphocholine belongs 
to a group of new antineoplastic substances, the alkyl- 
phosphocholines, and is structurally different from the 
alkyllysophosphoglycerides and acyllysophospho- 
glycerides (Fig. 1). Hexadecylphosphocholine is only 
slowly metabolized in vivo [3] and recently it could be 
shown that this phospholipid analogue inhibits protein 
kinase C [4,5]. 
2.1 . Materials 
[ melllyl-‘HICholine chloride (2.8-3. I TBq/mmol) and [Merlryl- 
“Clphosphocholine (2.04 GBq/mmol) were from Amersham 
(Braunschweig, Germany). Hexadecylphosphocholine was a gift from 
Asta Pharma (Frankfurt am Main, Germany). Silica gel 60 HPTLC 
plates and all solvents and reagents (reagent grade) were purchased 
from Merck (Darmstadt, Germany). The BCA-kit for protein deter- 
mination was obtained from Pierce (Weiskirchen, Germany). For 
quantification of radioactivity a Bcrthold LB 2821 HR thin-layer 
chromatography scanner (Berthold; Wildbad, Germany) was used. 
Dithiothreitol, phenylmcthylsulfonylfluoride, miscellaneous lipids 
and phosphatidylcholine precursdrs were from Sigma (Miinchen. 
Germany). 
2.2. Cell cullure 
In the present study it was demonstrated that hexade- 
cylphosphocholine interferes with the biosynthesis of 
phosphatidylcholine. Our results show that it inhibits 
the formation of phosphatidylcholine via the CDP- 
choline pathway at the level of the rate-limiting enzyme, 
CTP:phosphocholine cytidylyltransferase (EC 
2.7.7.15). Moreover, the lipid composition of MDCK 
cells was altered by treatment with 50 PM hexadecyl- 
phosphocholine for 24 h. 
Madin-Darby canine kidney (MDCK) cells were grown in Dul- 
becco’s minimal essential medium supplemented with 10% heat- 
inactivated fetal calf serum, 0.56g/l glutamine, 110 Ooo U/l penicillin 
and 0. I g/l streptomycin in plastic culture dishes (Nunc, Denmark). 
Media and culture reagents were obtained from Gibco (Karlsruhe. 
Germany), the penicillin and streptomycin were from Boehringer 
(Mannhcim, Germany). Cytotoxicity of hcxadecylphosphocholine 
was determined by the method of Culvenor et al. [6]. 
2.3. Radiolabelting and extraction of lipids and waorer-soluble 
precursors 
ABDrevia/ons: BCA, bicinchonicic acid; HPTLC, high-pcrforrnancc 
thin-layer chroma[ography; MDCK, Madin-Darby canine kidney; 
HcPC, Ilcs;ldccylI,hosphocholinc 
Corrc.rllo,rdcrrcco~ldre~~: C.C. Gcilcn, Inathut fiir Molckularbiologic 
utld Biochcmic, frcic UniversitBr Berlin, Arnitiiallcc 22, W-1000 
Ucrlin 33 (Dahlcm), Gcrmony. Fax: (49) (30) 83X 3702. 
[,,letlfy/-‘HJCholine labclling [7,4x IO’ Bq/ml] was initiated after 
3 h preincubation of the cells with SO JIM hexadecylphosphocholinc 
or, ahernatively, no supplements as control. After the incubation, 
cells were washed with ice-cold phosphate-buffcrcd saline (pH 7.2), 
rhcn harvcstcd with a cell lifter (Costar; Cambridge, USA) followed 
by modified lipid extraction according to Bligh ad Dyer [7], Shortly 
after lyophilisation of the cells, 50 ~1 mclhanol, 25 cl chloroform and 
20 ~1 water wcrc added. Samples wcrc stirred for 2 min on a vortex 
mixer and centrifuged at 13000~~ for IO min. Phase separation was 
accomplished by the addition of 2J ~1 chloroform and 25 id waler. 
The suspension and ccntrifugolion steps wcrc rcpcated, and 20 ~1 of 
~hc chloroform phases wcrc applied to silica gel 60 HPTLC plates US- 
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Fig. I. Chemical structure of hexadecylphosphocholine 
ing a HPTLC applicator (Linomat III; Camag, Berlin, Germany). 
Seventy ~1 of the upper phases were lyophilized, dissolved in 20 aI 
methanol/water (SO : 45, by vol.) and were likewise applied to 
HPTLC plates. 
2.4. Separatian and quanrijication of lipids arid water-soluble 
p?WUPSOps 
Lipids were separated according to Skipsi et al. [S], using the sol- 
vent chloroform/methanol/acetic acid/water (25:15:4:2, by vol.). 
Phosphatidylcholine precursors were separated in methanol/O.b% 
NaCl/25% aqueous NH3 (8:5:1, by vol.). Radioactivity was quan- 
tified by radioscanning. Phospholipids and their precursors were 
identified by calibrating the scanner with known standards. 
2.5. Proteirr determination 
Cellular protein was determined in each sample of the radiolabell- 
ing experiments by the BCA-assay [9] using bovine serum albumin as 
a standard. 
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2.6. Preparation of MDCK cell homogenate 
MDCK cells were harvested as described above in a buffer contain- 
ing 50 mM Tris-HCI, pi-l 7.4, 150 mM NaCI, 1 mM EDTA, 2 mM 
dithiothreitol, 0.03% Triton X-IOOand 4 mM NaNJ. After homogeni- 
zation by use of a dounce with a loose-fitting pestle (Braun, 
Melsungen, Germany) the protease inhibitor, phenylmethylsul- 
fonylfluoride, was rdded to achieve a I .O mM final concentration. 
2.1. CTP:phosphocltoline cytidylyltransferase assay 
The cytidylyltransferase activity was measured by a modified 
method of Sohal and Cornell [IO]. The reaction mixture contained 50 
mM Tris-HCI, pH 7.4, 0.03% Triton X-100. 100 mM NaCI, 10 mM 
MgCl2, 3 mM CTP, 1.5 mM [mer/tyC’*C]phosphocholine (specific 
radioactivity 20 Bq/nmol), liposomes (100 FM phosphatidylcholine/ 
100 PM oleic acid) and 5 gl of MDCK cell homogenate in a final 
volume of SOal. After incubation for 30 min at 37°C the reaction was 
stopped by freezing the samples in liquid nitrogen. The samples were 
lyophilized, dissolved in 20 aI methanol/water (I:], v/v) and applied 
to HPTLC plates. After developing in a solvent system containing 
methanol/O.b% NaCl/25% aqueous NH3 (8:5:1, by vol.), the 
radioactivity was determined by radioscanning. One Unit of enzyme 
activity is defined as nmol of CDP-choline formed per min. 
3. RESULTS 
It could be shown that hexadecylphosphocholine did 
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Fig. 2. Effect of llexadccylphosplrocliolilicon the time-dcpcndcnt incorporation of radiolabcllcd choline into phoshatidylcholinc and its precursors 
in MDCK-cells. MDCK-cells grown t~c~~iflucncc wcrc preincubntcd with 50pM licxadccylpliospllocliolinc for 3 h. Then pulse medium was added 
containing 7.4 x IO’ Bq/ml (nretlt~l-‘Hjcholinc and 50 PM ltcxadccylphospltocllolirlc (e), For control cxpcrimenls IIO Ilcxadccylpllosphocllolirlc 
WPS added (0). After different incubation timcs,ns indicntcd in the figure, the cells wcrc mcchanicnlly harvcstcd and phospliatidylcliolinc and 
phosphotidylcholinc precursors were analyscd as dcscribcd in section 2. The vnlucs of incorporated radioactivity arc given in dpn~/mp cellular pro. 
tciu (II m 3). 
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Fig. 3. Effect of hexadecylphosphocholine on cytidylyltransferase 
(CT) activity in MDCK-cell homogenate. 5 ~1 of MDCK cell 
homogenate were used in the assay and various concentrations of hex- 
adecylphosphocholine dissolved in the assay buffer were added to the 
reaction mixture. The activity is given in U/ml homogenate ()I= 3). 
not show any apparent oxic effect on MDCK-cells up 
to a concentration of 200 PM. Morphological changes 
occurred only at concentrations higher than 1 mM hex- 
adecylphosphocholine (data not shown). 
To examine the effect of hexadecylphosphocholine 
on phosphatidylcholine biosynthesis, we measured its 
influence on [methyl-3H]choline incorporation into 
phosphatidylcholine precursors and phosphatidylcho- 
line. For this purpose, MDCK-cells were preincubated 
for 3 h with 50 FM hexadecylphosphochoiine, followed 
by the addition of radiolabelled choline. At different 
times, as indicated in Fig. 2, the cells were washed and 
harvested. After an incubation period of 6 h in hexade- 
cyl-phosphocholine-treated cells the incorporation rate 
of radiolabelled choline into phosphatidylcholine was 
reduced to about 50% of the control experiments, 
whereas the incorporation into the phosphocholine 
pool was increased 3-fold, The incorporation into the 
choline pool seemed to be unaffected (Fig. 2) and the in- 
corporation into CDP-choline was not sufficiently 
detectable in these experiments, because the CDP- 
choline pool represented less than 1% of the total 
aqueous metabolites. 
The activity of CTP : phosphocholine cytidylyltrans- 
ferase in MDCK cell homogenate was measured in an 
assay containing liposomes (Fig. 3). The liposome- 
stimulated activity was decreased by 45% in the pre- 
sence of 10 ,uM hexadecylphosphocholine. It is inter- 
esting to note that the inhibitory effect did not increase 
when higher concentrations of hexadecylphosphocho- 
line were added to the assay buffer. This observation 
might be due to the critical micellar concentration of 
hexadecylphosphocholine (CMC), which is in the range 
of 100 pM (data not shown). 
In order to investigate the effect of long-term hexade- 
cylphosphocholine treatment on the lipid composition 
of MDCK cells we added hexadecylphosphocholine (50
PM) to the culture medium for 24 h and determined the 
amount of the different lipids in the total lipid extract. 
The results, shown in Table I, indicate that hexadecyl- 
phosphocholine compared with the control experi- 
ments, reduces the content of phosphatidylcholine from 
36.O-tO.9% to 29.9 kO.2% of total lipid, whereas the 
content of phosphatidylethanolamine increases from 
19.3 k 0.9% to 24.3 t0.9%. Triacylglycerol, sphingo- 
myelin, phosphatidylserine, phosphatidyIinosito1 and 
cardiolipin were unaffected. The amount of total lipids 
was not altered (99.5 f 9.5 pg/lOb cells for control cells 
and 92.9 -c 5.0 pg/lO” cells for treated cells). 
4. DISCUSSION 
Phosphatidylcholine biosynthesis occurs mainly via 
the CDP-choline pathway (Kennedy pathway) [I, 111, 
but a second pathway via N-methylation of 
phosphatidylethanolamine has also been described [It]. 
The data presented here demonstrate that the 
phospholipid analogue, hexadecylphosphocholine, in- 
hibits phosphatidylcholine biosynthesis via the CDP- 
Table I 
Effect of hcxadccylphosphocholinc on the lipid composition of MDCK-cells 
MDCK-cells grown to conflucncc wcrc incubated with 50~M hcxadecylphosphocholinc for 24 h. 
For conlrol cxpcrimcnts no supplcmcnrs wcrc added. The cells wcrc mcchanicnlly harvcskd and 
Ihc lipidswcrc cxtracbzd xcording the mclhod of Bligh and Dyer [l7] as dcscribcd ia section 2. ‘Illc 
lipids wcrc scparatcd by HPTLC, scaincd wirh cupric suifarc rcagcnt and quantlfrcd by den- 
sitomctric vidcoscanning, The values arc given in % of the rok~l lipid exIrac( (n = 3). PC, 
pliosptl:ltidylcllolinc; SM, spllingomyclin; PS, phosphatidylscrinc; PI, phosphatidytinositol; PE, 
phospl~;~~idylc~hanolaminc; CL, cardiolipin; TG, triocytglyccrol. 
SM PC PS PI PE CL I-G 
Control* 5.3~0.6 36,0+0.9 R.bk I.2 5.9*0,7 IY.3kO.9 10.8*11.4 14.lkl,4 
Hct’C** 4.YkO.6 29,9+0,2 Y.6k 1.0 S.3kOo.4 24.3kOo.9 IO.1 k 1.6 tS.Yk lzl 
‘I’otal lipids (IWQ) WYC 9Y.5 2 9.5 &IO cells for control cells* and Y2.Y k S.O&lOL cc115 for 
~Ict~C~trrnled cells** 
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choline pathway in MDCK cells. It is known that the 
rate-limiting step of this pathway is catalyzed by 
CTP:phosphocholine cytidylyltransferase (EC 
2.7.7.15) [I]. The accumulation of radiolabelled 
phosphocholine in hexadecylphosphocholine-treated 
cells and the inhibition of the cytidylyltransferase in
vitro suggest that the rate-limiting step of 
phosphatidylcholine biosynthesis the target of inhibi- 
tion. 
In earlier studies it was demonstrated that 
CytidyIyltransferase activity is regulated by transloca- 
tion of the inactive cytosolic form to the membrane, 
where it becomes active. A number of factors have been 
implicated in this translocation. Diacylglycerol [13 1, 
fatty acids [14], lysophosphatidylethanolamine [15] and 
a protein dephosphorylation reaction [16] will each 
facilitate association of cytidylyltransferase with mem- 
branes. Conversely, Iysophosphatidylcholine [ f7] and 
sphingosine [lo] inhibit the activity of 
cytidylyltransferase. Since hexadecylphosphocholine s 
structurally similar to lysophosphatidylcholine it may 
interfere with the translocation and hence act as a direct 
inhibitor of the cytidylyltransferase. 
On the other hand, hexadecylphosphocholine is an 
inhibitor of protein kinase C [4,5] and therefore the 
possibility of an indirect action should be taken into ac- 
count. In further studies we will address ourselves to the 
mechanism underlying the described inhibitory effect. 
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